E³ - The Beauty of Basic Knowledge: Hybrid Imaging
E³ 24C - Infection and inflammation
Lectures
1
Chairperson's introduction
05:00Clemens C. Cyran, München / DE
2
Hybrid imaging of infection and inflammation in paediatric patients
15:00Ora Israel, Haifa / IL
3
Inflammation of orthopaedic prosthesis
15:00Jose Luis Vercher Conejero, Barcelona / ES
4
FDG PET/CT in patients with signs and symptoms of GCA and PMR
15:00Riemer Slart, Groningen / NL
5
Panel discussion: Is hybrid imaging troubleshooter or standard of care in infection and inflammation?
10:00Panel discussion: Is hybrid imaging troubleshooter or standard of care in infection and inflammation?
5 min
Chairperson's introduction
Clemens C. Cyran, München / Germany
15 min
Hybrid imaging of infection and inflammation in paediatric patients
Ora Israel, Haifa / Israel
1. To define the clinical indications for hybrid imaging in children with known or suspected infectious and inflammatory processes.
2. To present the performance indices of hybrid imaging in children with known or suspected infection and inflammation.
3. To define the clinical and technical challenges as well as recommended imaging protocols for hybrid imaging in the paediatric patient population.
2. To present the performance indices of hybrid imaging in children with known or suspected infection and inflammation.
3. To define the clinical and technical challenges as well as recommended imaging protocols for hybrid imaging in the paediatric patient population.
15 min
Inflammation of orthopaedic prosthesis
Jose Luis Vercher Conejero, Barcelona / Spain
1. To understand the role of hybrid imaging in infection and inflammation.
2. To learn the limitations and pitfalls of hybrid imaging, mainly SPECT/CT and PET/CT, to diagnose infections and inflammation.
3. To learn about the different radiopharmaceuticals that may be used in the inflammation process.
2. To learn the limitations and pitfalls of hybrid imaging, mainly SPECT/CT and PET/CT, to diagnose infections and inflammation.
3. To learn about the different radiopharmaceuticals that may be used in the inflammation process.
15 min
FDG PET/CT in patients with signs and symptoms of GCA and PMR
Riemer Slart, Groningen / Netherlands
1. To understand the patient’s journey in GCA and PMR.
2. To get informed about the indications, value, procedure, and reading of FDG PET/CT in the diagnosis and therapy-monitoring of GCA and PMR.
3. To get informed about novel developments of PET/CT in GCA and PMR.
2. To get informed about the indications, value, procedure, and reading of FDG PET/CT in the diagnosis and therapy-monitoring of GCA and PMR.
3. To get informed about novel developments of PET/CT in GCA and PMR.
10 min
Panel discussion: Is hybrid imaging troubleshooter or standard of care in infection and inflammation?